Physician profile
Alexander Smith
NPI 1154854800
$6,592.50
in general payments reported to CMS, 2019-2025
14 companies · $3,626 in 2025
The $3,626 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $220 · 2023: $1,515 · 2024: $1,231 · 2025: $3,626.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,091 · Travel and Lodging: $2,053 · Education: $229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,090.92 |
| Travel and Lodging | $2,052.65 |
| Education | $228.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,690.12 | 2024-2025 | Evera Mri Xt Dr Surescan, Aurora Ev-Icd Mri Surescan, Micra |
| Boston Scientific Corporation | $1,522.79 | 2023-2025 | General - Therapies, Farapulse, General - Tachy |
| Abbott Laboratories | $886.72 | 2022-2025 | Aveir, Ensite Precision, Gallant |
| Philips North America LLC | $617.99 | 2023-2025 | Igt Devices Undivided, Lm Undivided |
| Biosense Webster, INC. | $380.61 | 2024-2025 | Carto 3 |
| Amgen INC. | $125.46 | 2023 | |
| Glaxosmithkline, LLC. | $108.13 | 2025 | Ojjaara |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $88.77 | 2023 | Lifevest |
| Abiomed | $43.55 | 2022 | |
| Galvanize Therapeutics, INC | $35.65 | 2025 | Aliya System |
| Novartis Pharmaceuticals Corporation | $31.16 | 2025 | |
| Pfizer INC. | $26.02 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.53 | 2025 | Xifaxan |
| Astrazeneca Pharmaceuticals LP | $17.00 | 2023 | Andexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.